🇺🇸 FDA
Patent

US 6294322

Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1

expired A61KA61K2039/545A61K2039/55516

Quick answer

US patent 6294322 (Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/545, A61K2039/55516, A61K2039/55566, A61K2039/55577